No abstract available
Keywords:
adipose tissue; endocrine-related cancers; metabolic markers; metabolism; obesity.
PubMed Disclaimer
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Comment on
- Editorial on the Research Topic Obesity and metabolism in endocrine-related cancers
References
-
-
Park J, Morley TS, Kim M, Clegg DJ, Scherer PE. Obesity and cancer–mechanisms underlying tumour progression and recurrence. Nat Rev Endocrinol. (2014) 10:455–65. doi: 10.1038/nrendo.2014.94, PMID:
-
DOI
-
PMC
-
PubMed
-
-
Lengyel E, Makowski L, DiGiovanni J, Kolonin MG. Cancer as a matter of fat: the crosstalk between adipose tissue and tumors. Trends Cancer. (2018) 4:374–84. doi: 10.1016/j.trecan.2018.03.004, PMID:
-
DOI
-
PMC
-
PubMed
-
-
Jin HR, Wang J, Wang ZJ, Xi MJ, Xia BH, Deng K, et al. Lipid metabolic reprogramming in tumor microenvironment: from mechanisms to therapeutics. J Hematol Oncol. (2023) 16:103. doi: 10.1186/s13045-023-01498-2, PMID:
-
DOI
-
PMC
-
PubMed
-
-
Goswami S, Zhang Q, Celik CE, Reich EM, Yilmaz ÖChecktae. Dietary fat and lipid metabolism in the tumor microenvironment. Biochim Biophys Acta Rev Cancer. (2023) 1878:188984. doi: 10.1016/j.bbcan.2023.188984, PMID:
-
DOI
-
PMC
-
PubMed
-
-
Prendeville H, Lynch L. Diet, lipids, and antitumor immunity. Cell Mol Immunol. (2022) 19:432–44. doi: 10.1038/s41423-021-00781-x, PMID:
-
DOI
-
PMC
-
PubMed